Search research articles
Contact Us
Filters
Showing results (1-10 of 104) with videos related to
Page
of 11
Sort By:
Edinburgh Medical and Surgical Journal
|
October 18, 2018
On the Utility of the Nicotiana Tabacum in Some Cases of Phlegmasiæ
Robert L Page
Journal of the American College of Cardiology
|
January 25, 2023
The Real-World Price of Switching to an ARNI: A Case for De Novo Sacubitril/Valsartan Initiation
Robert L Page
European Heart Journal
|
January 11, 2024
Cannabis by any name does not smell as sweet: potential cardiovascular events with medical cannabis
Robert L Page Ii
JACC. Heart Failure
|
March 21, 2025
Where Are All the Heart Failure GDMT Clinics?: A Call to Action
Robert L Page, Prateeti Khazanie
Journal of Cardiac Failure
|
May 23, 2017
Ground Hog Day: Do We Need Another Analysis of Diuretic Dose and Outcomes in Heart Failure Patients?
Robert L Page, JoAnn Lindenfeld
The Journal of Cardiovascular Nursing
|
August 22, 2015
Foundations of Pharmacotherapy for Heart Failure With Reduced Ejection Fraction: Evidence Meets Practice, Part I
Sara Paul, Robert L Page
Journal of the American Heart Association
|
November 22, 2024
Smoking or Vaping Cannabis and Cardiovascular Function: Is Δ-9-Tetrahydrocannabinol the Main Culprit?
Onyedika J Ilonze, Robert L Page
The Journal of Cardiovascular Nursing
|
March 31, 2016
Foundations of Pharmacotherapy for Heart Failure With Reduced Ejection Fraction: Evidence Meets Practice, Part II
Colleen K McIlvennan, Robert L Page
Pharmacotherapy
|
March 24, 2006
Sulfonamide allergies and outcomes related to use of potentially cross-reactive drugs in hospitalized patients
Brian A Hemstreet, Robert L Page
The American Journal of Geriatric Pharmacotherapy
|
February 14, 2007
The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use
Robert L Page, J Mark Ruscin
Page
of 11
Search research articles
Search
Showing results (1-10 of 104) with videos related to
Sort By:
Page
of 11
Edinburgh Medical and Surgical Journal
|
October 18, 2018
On the Utility of the Nicotiana Tabacum in Some Cases of Phlegmasiæ
Robert L Page
Journal of the American College of Cardiology
|
January 25, 2023
The Real-World Price of Switching to an ARNI: A Case for De Novo Sacubitril/Valsartan Initiation
Robert L Page
European Heart Journal
|
January 11, 2024
Cannabis by any name does not smell as sweet: potential cardiovascular events with medical cannabis
Robert L Page Ii
JACC. Heart Failure
|
March 21, 2025
Where Are All the Heart Failure GDMT Clinics?: A Call to Action
Robert L Page, Prateeti Khazanie
Journal of Cardiac Failure
|
May 23, 2017
Ground Hog Day: Do We Need Another Analysis of Diuretic Dose and Outcomes in Heart Failure Patients?
Robert L Page, JoAnn Lindenfeld
The Journal of Cardiovascular Nursing
|
August 22, 2015
Foundations of Pharmacotherapy for Heart Failure With Reduced Ejection Fraction: Evidence Meets Practice, Part I
Sara Paul, Robert L Page
Journal of the American Heart Association
|
November 22, 2024
Smoking or Vaping Cannabis and Cardiovascular Function: Is Δ-9-Tetrahydrocannabinol the Main Culprit?
Onyedika J Ilonze, Robert L Page
The Journal of Cardiovascular Nursing
|
March 31, 2016
Foundations of Pharmacotherapy for Heart Failure With Reduced Ejection Fraction: Evidence Meets Practice, Part II
Colleen K McIlvennan, Robert L Page
Pharmacotherapy
|
March 24, 2006
Sulfonamide allergies and outcomes related to use of potentially cross-reactive drugs in hospitalized patients
Brian A Hemstreet, Robert L Page
The American Journal of Geriatric Pharmacotherapy
|
February 14, 2007
The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use
Robert L Page, J Mark Ruscin
Page
of 11